Translocation of non-natural chemical entities through anthrax protective antigen pore
US-9498538-B2 · Nov 22, 2016 · US
US10539571B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10539571-B2 |
| Application number | US-201615063774-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 8, 2016 |
| Priority date | Sep 9, 2013 |
| Publication date | Jan 21, 2020 |
| Grant date | Jan 21, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method of proteolyzing a protein, including immobilizing a protein in at least one pore of a porous body, and contacting the protein immobilized in the pore and a protease immobilized on a solid surface such that the protease selectively accesses a site of the protein and proteolyzes the protein at the site.
Opening claim text (preview).
What is claimed is: 1. A kit for proteolyzing a protein, comprising: at least one porous body having a plurality of pores in which a protein is to be immobilized; and a plurality of particles having an average particle diameter larger than an average pore diameter of the pores, wherein the particles have a surface modified by a spacer such that a protease has been immobilized or is to be immobilized on the surface by specific binding with the spacer, a ligand molecule is immobilized in the pores of the porous body, the ligand molecule is capable of site-specifically interacting with and controlling an orientation of the protein to be immobilized, and the average particle diameter or the average pore diameter is sized such that each of the pores has a limit to the region accessible to the protease, and that the protein is to be immobilized with a tip portion extending into the region accessible to the protease. 2. The kit of claim 1 , wherein the particles have a protease immobilized on the surface of the particles modified by the spacer. 3. The kit of claim 1 , wherein the average particle diameter of the particles is 100 nm or greater and the average pore diameter of the pores in the porous body is in a range of from 30 nm to 150 nm, provided that the average particle diameter is larger than the average pore diameter. 4. The kit of claim 1 , wherein the ligand molecule is capable of site-specifically interacting with Fc domain of an antibody. 5. The kit of claim 1 , wherein the ligand molecule is at least one selected from the group consisting of protein A and protein G. 6. The kit of claim 1 , wherein the spacer allows specific binding with the protease without deactivating the protease. 7. The kit of claim 1 , wherein the spacer has a molecular diameter of 5 nm or less. 8. The kit of claim 1 , wherein the spacer has a molecular diameter of 2 nm or less. 9. The kit of claim 1 , wherein the spacer has a molecular weight of 2000 or less. 10. The kit of claim 2 , wherein the spacer has a molecular weight of 800 or less. 11. The kit of claim 1 , wherein the spacer has one of an amino group, an amide group, an ester group, an epoxy group, a carboxyl group, biotin, avidin, and a chelate. 12. The kit of claim 1 , wherein the spacer has an ester group. 13. The kit of claim 1 , wherein the spacer has an activated ester group. 14. A kit for proteolyzing a protein, comprising: at least one porous body having a plurality of pores in which a protein is immobilized; and a plurality of particles having an average particle diameter larger than an average pore diameter of the pores, wherein the particles have a surface on which a protease has been immobilized, a ligand molecule is immobilized in the pores of the porous body, the ligand molecule immobilized in the pores is capable of site-specifically interacting with the immobilized protein, thereby an orientation of the protein immobilized in the pores is controlled, the average particle diameter or the average pore diameter is sized such that the protease immobilized on the surface of the particles has access to the protein immobilized in the pores of the porous body, the pores each have a limit to the region accessible to the protease, and the protein immobilized in the pores has a tip portion extending into the region accessible to the protease.
by hydrolysis {, i.e. solvolysis in general} · CPC title
by chemical modification of precursor peptides · CPC title
Trypsin; Chymotrypsin · CPC title
Chemical aspects of mass spectrometric analysis of biological material · CPC title
acting on peptide bonds (3.4) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.